Canaccord Genuity analyst Neil Maruoka likes the recent developments at ProMetic Life Sciences (ProM... Read More
Its share price has been falling steadily all year, but EdgeHill Partners chief investment officer J... Read More
Slipping timelines have Canaccord Genuity analyst Neil Maruoka lowering his price target on ProMetic... Read More
A new analyst covering ProMetic Life Sciences (ProMetic Life Sciences Stock Quote, Chart, News: TSX:... Read More
Canaccord Genuity analyst Neil Maruoka says ProMetic Life Science’s (ProMetic Life Science Sto... Read More
A warrant exercise reduces the financial risk of ProMetic Life Sciences (TSX:PLI), says Echelon Weal... Read More
It’s much too early to tell if ProMetic Life Sciences’ (ProMetic Life Sciences Stock Quo... Read More
The pending acquisition of Telesta Therapeutics by ProMetic Life Sciences (TSX:PLI) will add more th... Read More
Another milestone for ProMetic Life Sciences (TSX:PLI) has Paradigm Capital analyst Christopher Lam ... Read More
The recent healing of a patient in the United States with ProMetic Life Sciences’ (TSXV:PLI) p... Read More
The results from ProMetic Life Science’s (ProMetic Life Sciences Stock Quote, Chart, News: TSX... Read More
In the Canadian Life Sciences sector, 2015 was defined by one word: Valeant. Valeant Pharmaceutical�... Read More
ProMetic Life Sciences (TSX:PLI) was one of the top performing Canadian life sciences stocks in 2015... Read More
Paradigm Capital analyst Christoper Lam says today’s news from ProMetic Life Sciences (TSX:PLI... Read More
Paradigm Capital analyst Christopher Lam likes the partnership ProMetic Life Sciences (TSX:PLI) sign... Read More
Prometic Life Sciences’ (TSX:PLI) second plasma‐derived protein is headed to clinic, and Par... Read More
ProMetic Life Sciences (ProMetic Life Sciences Stock Quote, Chart, News: TSX:PLI) has reached a key ... Read More
This past Friday, the tape was telling investors that something was up at Prometic Life Sciences (Pr... Read More
Share
Tweet
pin
Share